Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ProMIS Neurosciences Inc. (PMN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 EFFECT Form EFFECT - Notice of Effectiveness:
10/02/2023 EFFECT Form EFFECT - Notice of Effectiveness:
09/27/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
09/27/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
08/22/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/22/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "ProMis Neurosciences Inc.",
"ProMis Neurosciences Inc.",
"PROMIS NEUROSCIENCES INC. UNIT PURCHASE AGREEMENT",
"Registration Rights Agreement",
"ProMIS Neurosciences Announces $20.4 Million Private Placement Financing"
08/14/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/14/2023 8-K Quarterly results
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/14/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/14/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Corporation Name / Dénomination sociale"
07/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
06/30/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
06/30/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/01/2023 ARS Form ARS - Annual Report to Security Holders:
06/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/18/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 8-K Quarterly results
05/08/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/08/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug Application for PMN310 in Alzheimer’ s Disease"
04/27/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/27/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/03/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/24/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/17/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/08/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
03/08/2023 10-K Annual Report for the period ended December 31, 2022
12/06/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/16/2022 8-K Quarterly results
11/14/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy